Michael Xiang

Michael Xiang practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Michael Xiang's NPI, 1477930519, was assigned on April 28, 2015. Michael Xiang graduated from Harvard Medical School in 2015. Michael Xiang holds California license A144129.

Michael Xiang's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Michael Xiang's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Michael Xiang is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group (UCLA Health). Dmand AI also links Michael Xiang to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Xiang practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Michael Xiang's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Michael Xiang is board certified in radiation oncology by the American Board of Radiology. Michael Xiang is licensed in California.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Michael Xiang treats.

CMS data shows 2,522 Medicare services from Michael Xiang across 19 procedure codes in 2024, for 230 Medicare patients. Medicare paid $197,511 for them. Every service was in an office.

CMS counts 230 Medicare patients who saw Michael Xiang in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have cancer, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Xiang's median patient age at 68, with 57% women.

In 2024, Michael Xiang wrote 270 Medicare Part D claims for 68 patients. 85% of them were for generic drugs. CMS names the drug for 163 of them, across 6 drugs with 11 or more claims each, at $30,181 in total drug cost. In 2023, CMS named 104 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Michael Xiang for performance year 2024, reported as part of a group. Michael Xiang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Xiang as offering telehealth.

Dmand AI links 4 papers to Michael Xiang, published from 2016 to 2019. Michael Xiang's most frequent co-authors are David Alan Frank, MD, Karen Elizabeth Hoffman, MD and Neil E. Martin, MD.

CMS Open Payments shows 3 general payments to Michael Xiang from 1 drug or device company in 2023. Travel and lodging make up the largest share, 78% of the total. Siemens Medical Solutions USA, Inc. paid the most, $617.

Michael Xiang graduated from Harvard Medical School in 2015. Michael Xiang is a member of ASTRO.

Michael Xiang is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.